Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis
Listen to this summary
This study investigates the cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion (MACS), specifically examining its impact on blood pressure, cardiac fat depots, and other cardiovascular risk factors. The results indicate that metyrapone treatment significantly reduced both systolic and diastolic blood pressure and decreased epicardial fat, while no changes were observed in cardiac function or morphology. Overall, the findings suggest that cortisol-lowering therapy may improve cardiovascular health in patients with MACS.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Journal of clinical endocrinology and metabolism
View all →Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
Approach to the Patient: Cases of Hormonal Management in Older Transgender and Gender Diverse Adults
Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
The Utility of Salivary 11-Dehydrodexamethasone as a Marker of Dexamethasone Absorption
More in Pediatrics
View all →Aug 7, 2026 · European heart journal
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies
Aug 7, 2026 · Critical care medicine
Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis
Aug 7, 2026 · Pediatric nephrology (Berlin, Germany)
Anti-rituximab antibodies: implications for clinical outcomes and safety in pediatric idiopathic nephrotic syndrome
Aug 7, 2026 · Critical care medicine
Rethinking Muscle Wasting in Critical Illness: A Systematic Review and Meta-Analysis of Myofiber Size and Protein Turnover
Aug 7, 2026 · Critical care medicine
Telemedicine Critical Care Billing For Hospitalized Medicare Fee-For-Service Beneficiaries, 2018-2024
Aug 7, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


